Understanding US Physician and Pharmacist Attitudes Toward Biosimilar Products: A Qualitative Study.

Douglas J Rupert Alyssa M JordanMarina A ZiemianRachel M Brown Neil S Fleming R Craig Lefebvre

Published in: BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy (2022)

Educating physicians and pharmacists about biosimilars-including how biosimilarity is defined and operationalized, the structure of the biosimilar approval process, and how analytical data can ensure biosimilar safety and efficacy-will be important for reducing healthcare providers' concerns and increasing biosimilar adoption in the US.

Keyphrases

healthcare
primary care
electronic health record
emergency department
big data
machine learning
artificial intelligence
mass spectrometry
social media
liquid chromatography